SPC379
Pegcetacoplan
Status:
VeittApplication date:
30.5.2022Application published:
15.7.2022Grant published:
15.2.2024
Max expiry date:
13.12.2036Medicine name:
ASPAVELIMedicine for children:
No
Timeline
Today
30.5.2022Application
15.7.2022Publication
15.2.2024Registration
13.12.2036Expires
Marketing license
IS authorization number:
EU/1/21/1595/001-002Date:
30.12.2021
Foreign authorization number:
EU/1/21/1595Date:
13.12.2021
Owner
Name:
Apellis Pharmaceuticals, Inc.Address:
100 5th Avenue, Waltham US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128 Reykjavík
Patent
Number:
EP3660033